p53 and p21WAF1/CIP1/SDI1 gene products in barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction
- 1 November 1996
- journal article
- Published by Elsevier in Human Pathology
- Vol. 27 (11) , 1211-1220
- https://doi.org/10.1016/s0046-8177(96)90317-2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Apoptosis, cancer and the p53 tumour suppressor geneCancer and Metastasis Reviews, 1995
- Barrett's esophagus, dysplasia, and adenocarcinomaHuman Pathology, 1994
- All in the (cancer) familyNature Genetics, 1993
- The molecular genetics of colorectal neoplasiaGastroenterology, 1993
- p53 Protein Detected By Immunohistochemical Staining is Not Always MutantDisease Markers, 1993
- The integration of molecular genetics into cancer managementCancer, 1992
- Changing pattern of distribution of carcinoma of the stomachBritish Journal of Surgery, 1990
- Barrett's Esophagus; Development of Dysplasia and AdenocarcinomaGastroenterology, 1989
- The Relationship Between Columnar Epithelial Dysplasia and Invasive Adenocarcinoma Arising in Barrett’s EsophagusAmerican Journal of Clinical Pathology, 1987
- Comparative features of esophageal and gastric adenocarcinomas: Recent changes in type and frequencyHuman Pathology, 1986